Thyrocare Technologies Limited

Symbol: THYROCARE.BO

BSE

603.8

INR

Market price today

  • 50.3318

    P/E Ratio

  • 0.9063

    PEG Ratio

  • 31.97B

    MRK Cap

  • 0.00%

    DIV Yield

Thyrocare Technologies Limited (THYROCARE-BO) Financial Statements

On the chart you can see the default numbers in dynamics for Thyrocare Technologies Limited (THYROCARE.BO). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Thyrocare Technologies Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

01400.71388.41176.9
800.9
842.4
1119.6
1160.9
1107.1
893.8

balance-sheet.row.short-term-investments

012231252.11044.9
713.9
793.3
1021.4
1062
1003.6
843

balance-sheet.row.net-receivables

0856.7944.8513.5
170
124.6
99.1
64.2
140.8
124.5

balance-sheet.row.inventory

0276.7245.3233.6
206.2
180.8
170.5
145
107.2
73.7

balance-sheet.row.other-current-assets

053.2112.828.4
0.1
196.5
16.3
0
65.6
14.8

balance-sheet.row.total-current-assets

02729.42700.22404.4
1519.9
1360.2
1424
1495.3
1366.6
1106.7

balance-sheet.row.property-plant-equipment-net

01944.31867.91600.9
1725.8
1872.5
1901.8
1686.2
1523.8
1546.3

balance-sheet.row.goodwill

01002.81002.81002.8
1002.8
1068.6
1068.6
1068.6
1068.6
0

balance-sheet.row.intangible-assets

07.98.39.7
11.6
16.6
17.1
6.4
12.6
0

balance-sheet.row.goodwill-and-intangible-assets

01010.71011.11012.5
1014.4
1085.2
1085.7
1075
1081.2
469.3

balance-sheet.row.long-term-investments

0223.1243.8270.7
282.5
248.5
215.4
6.3
50.2
-826.9

balance-sheet.row.tax-assets

0122.764.956.3
20.3
51.4
52.3
37.9
23.4
8.7

balance-sheet.row.other-non-current-assets

0297188.7113.2
143.3
129.4
110.8
77.6
65.9
1976

balance-sheet.row.total-non-current-assets

03597.83376.43053.6
3186.3
3387
3366
2882.9
2744.4
2185.5

balance-sheet.row.other-assets

0000
0.1
0
0
0
0
0

balance-sheet.row.total-assets

06327.26076.65458
4706.3
4747.2
4790
4378.3
4111.1
3292.2

balance-sheet.row.account-payables

0239.9165.3250.1
218.6
75.1
65.9
13
18.4
8.3

balance-sheet.row.short-term-debt

071.95030.4
42.5
10.4
5.5
117.4
7.1
0

balance-sheet.row.tax-payables

018.318.318.6
9.7
10
10.1
12
17.4
0

balance-sheet.row.long-term-debt-total

0161.215754.5
81.9
25
-70.6
72.5
55
0

Deferred Revenue Non Current

00091.9
81.6
-69.5
0.1
0.2
3.4
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0398.4336.5312.5
249.1
74.8
99.5
136.8
104.8
64.7

balance-sheet.row.total-non-current-liabilities

0204165.7234.2
222.9
190.1
154.1
124
123.2
95.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0233.120784.9
99.4
0
0
0
0
0

balance-sheet.row.total-liab

0975810.91185.2
1039.8
396
357.1
300.2
275.3
168.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

0529.3529528.7
528.4
527.9
537.2
536.9
536.9
505.4

balance-sheet.row.retained-earnings

03434.23568.82599.2
2010.1
2715.2
2186.5
1890.8
1947.2
1867.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

01255.91244.11225.8
1200.8
1178.7
1809.5
1769.8
1770.2
0

balance-sheet.row.other-total-stockholders-equity

0123.6-76.2-80.9
-72.8
-70.6
-100.3
-119.5
-418.6
390.5

balance-sheet.row.total-stockholders-equity

053435265.74272.8
3666.5
4351.2
4432.9
4078.1
3835.7
2763.7

balance-sheet.row.total-liabilities-and-stockholders-equity

06327.26076.65458
4706.3
4747.2
4790
4378.3
4111.1
3292.2

balance-sheet.row.minority-interest

09.200
0
0
0
0
0
360.1

balance-sheet.row.total-equity

05352.25265.74272.8
3666.5
4351.2
4432.9
4078.1
3835.7
3123.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

0221209.2211
239.9
206.6
200
1067
16.1
16.1

balance-sheet.row.total-debt

0233.120784.9
124.4
25
0
72.5
62.1
0

balance-sheet.row.net-debt

055.470.7-47.1
37.4
-24.1
-98.2
-26.3
-41.4
-50.8

Cash Flow Statement

The financial landscape of Thyrocare Technologies Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012

cash-flows.row.net-income

0874.122791525.4
1464.8
1374
1449.9
816.7
818
676.2
461.6
568.2

cash-flows.row.depreciation-and-amortization

0387.1338.7302.8
319.1
261.7
201
180.5
182.4
128.7
63.6
33.1

cash-flows.row.deferred-income-tax

0-247.4-731.2-522.2
-474.4
-653.3
-640.7
-453.9
-348.5
-297.2
0
0

cash-flows.row.stock-based-compensation

0211.723.216.8
20
19.3
17.1
24.4
17.7
8.2
0
0

cash-flows.row.change-in-working-capital

057.9-792.2-176.5
337.8
-6.5
21.7
55.7
8.7
-168.6
-26.2
-0.5

cash-flows.row.account-receivables

0-14.3-587.2-288.1
-60.3
-27.9
-37.1
5.2
-24.7
0
-15.7
1

cash-flows.row.inventory

0-31.4-11.7-27.4
-25.4
-10.3
-25.6
-37.8
-33.5
-10.5
-10.5
-1.5

cash-flows.row.account-payables

074.2-84.831.5
143.5
9.1
-1.3
-5.4
12.1
0
0
0

cash-flows.row.other-working-capital

029.4-108.5107.5
280
22.6
85.8
93.8
54.7
-158.1
0
0

cash-flows.row.other-non-cash-items

09.716.61
11.5
7.9
21.3
-181.6
-348.8
-299.7
-36.6
-141.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-436.5-378.3-266.9
-99
-402.5
-436.5
-363.7
-144.2
-99.9
-147
-688

cash-flows.row.acquisitions-net

030.242.542.5
0.3
13.4
-100
0.6
0.8
-591.5
0
0

cash-flows.row.purchases-of-investments

0-1919.9-1730-1361.1
-1328.4
-1151.5
-914.3
-1227.7
-1064.9
-1317.4
0
0

cash-flows.row.sales-maturities-of-investments

01932.51593.51042.1
1429
1406.8
979.2
1125.7
999.2
1773.5
0
0

cash-flows.row.other-investing-activites

03.8236.656.8
7.6
17.9
39.4
49.9
32.5
55.7
-372.1
-194.7

cash-flows.row.net-cash-used-for-investing-activites

0-389.9-235.7-486.6
9.5
-115.9
-432.2
-415.1
-176.8
-179.7
-519.1
-882.7

cash-flows.row.debt-repayment

0-55.3-53.8-25
-43.9
-17.1
0
-10
0
0
0
0

cash-flows.row.common-stock-issued

00.30.30.3
0.4
0.4
0
0
0
0.3
0
0

cash-flows.row.common-stock-repurchased

0-55.3-53.8-62.6
-14.3
-630
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-793.5-793.1-528.4
-1319.6
-268.6
-537.2
-402.9
-379
-189.9
0
0

cash-flows.row.other-financing-activites

0426.3-0.1
-270.4
-21
-101.5
-72.3
-70.5
-38.9
0
8.1

cash-flows.row.net-cash-used-provided-by-financing-activities

0-861.8-894.1-615.8
-1647.8
-936.3
-638.7
-485.2
-449.6
-228.4
0
8.1

cash-flows.row.effect-of-forex-changes-on-cash

000-2.5
0
0
0
1
0
0
0
586.3

cash-flows.row.net-change-in-cash

041.44.344.9
40.5
-49.1
-0.6
-4.6
51.7
-63.5
-56.7
170.9

cash-flows.row.cash-at-end-of-period

0177.7136.3132
89.6
49.1
98.2
98.8
102.5
50.8
114.2
170.9

cash-flows.row.cash-at-beginning-of-period

0136.313287.1
49.1
98.2
98.8
103.5
50.8
114.2
170.9
0

cash-flows.row.operating-cash-flow

01293.11134.11147.3
1678.8
1003.1
1070.3
895.7
678
344.6
462.4
459.2

cash-flows.row.capital-expenditure

0-436.5-378.3-266.9
-99
-402.5
-436.5
-363.7
-144.2
-99.9
-147
-688

cash-flows.row.free-cash-flow

0856.6755.8880.4
1579.8
600.6
633.8
532
533.8
244.7
315.4
-228.8

Income Statement Row

Thyrocare Technologies Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of THYROCARE.BO is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

income-statement-row.row.total-revenue

05266.75888.64946.2
4342.6
4029.1
3563.2
3043.9
2409.7
1829.6

income-statement-row.row.cost-of-revenue

01632.31696.91639
1170.9
1105.3
949.8
814.2
703.6
583.1

income-statement-row.row.gross-profit

03634.44191.73307.2
3171.7
2923.8
2613.4
2229.6
1706.1
1246.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.other-expenses

04.41821.2
11.5
41
70.1
37
20.9
0

income-statement-row.row.operating-expenses

02788.22173.11895.9
1755.2
1642.9
1353.4
1237.4
948
631.3

income-statement-row.row.cost-and-expenses

04420.538703534.9
2926.1
2748.2
2303.2
2051.7
1651.5
1214.4

income-statement-row.row.interest-income

013.87.17.9
7
6.6
5
2
0.3
3.4

income-statement-row.row.interest-expense

023.523.78.7
18.5
6.1
4.4
2.7
5.5
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-0.4227.961.8
-65.5
83.7
167.8
-184.3
124.7
60.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

04.41821.2
11.5
41
70.1
37
20.9
0

income-statement-row.row.total-operating-expenses

0-0.4227.961.8
-65.5
83.7
167.8
-184.3
124.7
60.8

income-statement-row.row.interest-expense

023.523.78.7
18.5
6.1
4.4
2.7
5.5
0

income-statement-row.row.depreciation-and-amortization

0387.1338.7302.8
319.1
261.7
201
180.5
182.4
128.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-

income-statement-row.row.operating-income

0865.52044.21455.9
1457.5
1290.9
1279.9
999
693
615.3

income-statement-row.row.income-before-tax

0885.92277.21524.7
1404.1
1380.6
1449.9
816.7
818
676.2

income-statement-row.row.income-tax-expense

0242.3515.8393.2
520.1
529.2
517.1
388.3
300
235.8

income-statement-row.row.net-income

0643.61761.41131.5
884
851.4
932.8
428.4
518
452.2

Frequently Asked Question

What is Thyrocare Technologies Limited (THYROCARE.BO) total assets?

Thyrocare Technologies Limited (THYROCARE.BO) total assets is 6327200000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.708.

What is company free cash flow?

The free cash flow is 16.845.

What is enterprise net profit margin?

The net profit margin is 0.118.

What is firm total revenue?

The total revenue is 0.151.

What is Thyrocare Technologies Limited (THYROCARE.BO) net profit (net income)?

The net profit (net income) is 643600000.000.

What is firm total debt?

The total debt is 233100000.000.

What is operating expences number?

The operating expences are 2788200000.000.

What is company cash figure?

Enretprise cash is 0.000.